Impact of PET on the Radiation Treatment of Hodgkins Lymphoma

E-ISSN： 1874-4729|2|3|169-174

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.2, Iss.3, 2009-07, pp. : 169-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody-Targeted Immunotherapy for Treatment of Non-Hodgkins Lymphoma

Current Pharmaceutical Biotechnology, Vol. 1, Iss. 4, 2000-12 ,pp. : 303-312

Bentham Science Publishers

Access to resources Recommend Favorite

Rituxan® Immunotherapy and Zevalin® Radioimmunotherapy in the Treatment of Non-Hodgkin's Lymphoma

Current Pharmaceutical Biotechnology, Vol. 4, Iss. 4, 2003-08 ,pp. : 221-238

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkin's Lymphoma

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 4, 2001-12 ,pp. : 301-311

Bentham Science Publishers

Access to resources Recommend Favorite

QOL in non-Hodgkin's and Hodgkins lymphoma

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 338, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Non-Hodgkin's Lymphoma: Review of Conventional Treatments

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 4, 2001-12 ,pp. : 279-291

Bentham Science Publishers

Access to resources Recommend Favorite